Tokyo, Japan

Kin-ya Kameda

This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Seiyaku Co., Ltd.. Active years: 1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kin-ya Kameda. Retrieved from https://idiyas.com/inventor/kin-ya-kameda-uce4wj46

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1979

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kin-ya Kameda: Innovator in Diabetes Treatment

Introduction

Kin-ya Kameda is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of diabetes. His innovative approach has led to the development of a unique method that offers hope to many patients suffering from this chronic condition.

Latest Patents

Kameda holds a patent for a method for treating diabetes. This method involves administering a therapeutically effective amount of a 2-(2,2-disubstituted)ethylimidazoline of the general formula (I), wherein R is a phenyl group or a 2-pyridyl group, or the pharmaceutically acceptable acid addition salts thereof, to a patient having diabetes. This patent represents a significant advancement in diabetes treatment.

Career Highlights

Kin-ya Kameda is associated with Daiichi Seiyaku Co., Ltd., a prominent pharmaceutical company. His work at this organization has allowed him to focus on innovative solutions for diabetes management. Kameda's dedication to research and development has positioned him as a key figure in the medical community.

Collaborations

Kameda has collaborated with notable colleagues, including Fumiyoshi Ishikawa and Yasushi Abiko. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kin-ya Kameda's contributions to diabetes treatment through his patented method highlight his role as an influential inventor in the medical field. His work continues to inspire advancements in healthcare and offers new possibilities for patients with diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…